A Dose-Ranging Study Of Valdecoxib 5 Mg, 10 Mg, And 20 Mg Once Daily Versus Placebo In Patients With Osteoarthritis Of The Knee (Japan)
Clinical trial NCT00650624 · COMPLETED
Trial details
- NCT number
- NCT00650624
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-06-01
- Enrollment
- 416
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.